Skip to content

Impact of the Pre-phonatory Inspiratory Volume on the Speech Quality of Neuromuscular Patients Dependent on Non-invasive Ventilation

Impact of the Pre-phonatory Inspiratory Volume on the Speech Quality of Neuromuscular Patients Dependent on Non-invasive Ventilation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03381937
Acronym
PREPHONO
Enrollment
15
Registered
2017-12-22
Start date
2018-02-06
Completion date
2020-01-31
Last updated
2019-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Diseases, Non Invasive Ventilation

Keywords

mechanical ventilation, noninvasive ventilation, neuromuscular disorder, phonation, mouthpiece ventilation

Brief summary

We want to demonstrate that modifications of the ventilation parameters are liable to improve the different characteristics of phonation (duration, intensity, prosody..) in neuromuscular patients who are dependent on non invasive ventilation.

Detailed description

Speech and communication quality depend on respiration efficiency. The respiratory involvement observed in neuromuscular disorders can impair speech quality in patients, while the underlying disease may also contribute to alter phonation. Nowadays, the first line treatment of neuromuscular chronic neuromuscular respiratory failure is noninvasive ventilation (NIV). With disease progression, it is used with increasingly duration during daytime. In that situation, mouthpiece ventilation is preferred as it allows efficient ventilation while being more comfortable for patients who can chose when they want to be ventilated. However, in that situation, patients do not receive ventilatory support while they are speaking which puts them in a less favorable situation for speech. We think that pre-phonation inspiratory volume is an essential part of speech quality. Without mechanical ventilation, this volume is reduced as a consequence of respiratory failure but it is liable to increase significantly if the patient used the volume delivered by the ventilator . We believe that phonation is improved by NIV by applying specific ventilation parameters in patients dependant on mechanical ventilation. The modification could be used by neuromuscular patients to improve speech quality; the patients would then be able to use their usual ventilatory support to improve phonation and modulation of their speech. In this crossover open labelled, randomised study, done in a single center (home ventilation unit of the referral center of Hospital Raymond Poincaré HUPIFO (University Hospital of Western Paris and Ile de France) (Garches, France)), phonation characteristics will be studied in 3 situations (during spontaneous breathing without ventilatory support, with the usual NIV parameters, with speech-specific NIV parameters) during which speech trials will be performed.

Interventions

speech trial during different ventilation conditions

Sponsors

Centre d'Investigation Clinique et Technologique 805
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

monocentric, open, randomize, crossover study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult patients (age \> or equal to 18) * chronic restrictive respiratory failure due to neuromuscular disease * spontaneous breathing autonomy of at least one hour during the days * stable clinical state * patient with middle school education level (able to read) * patients using life support ventilator ((Astral 150 (ResMed®), Elysée (ResMed®), Trilogy (Philips Respironics®), VentilogicLS (Weinman®), Vivo 40 (Breas®), PB560 ou Légendair (Covidien®), Monal T50 (Air liquide system®))

Exclusion criteria

* refusal to participate * unability to cooperate * illiterate patients * tracheostomised patients * spontaneous breathing autonomy \< 1h * cardiovascular instability * not registered with the social security system

Design outcomes

Primary

MeasureTime frameDescription
Phonation duration1 hourevaluation by the measurement of the longest duration of a sustained A sound. The subject is asked to sustain a vowel as long as possible during a respiratory cycle while being recorded. Phonation duration is measured (in seconds) on the recording

Secondary

MeasureTime frameDescription
Quality of prosodia1 hourevaluation of prosodia by listeners blinded to ventilation condition with a score based on the number of correct identification
Phonation flow1 hourMeasurement of the number of syllables/min during the reading of a predetermined text
Speech Intelligibility1 hourassessment of intelligibility during reading of preselected words by listeners blinded to ventilation condition with a validated scale
Phonation quality1 hourevaluation of the phonation quality by the patient with a horizontal visual analogical scale ranked from 0 to 10 (0= very poor quality and 10= very good quality). The scale is 10 cm long ; the patient indicate his perceived sensation on the scale and the according measure (between 0 and 10) is recorded
Breathing quality1 hourevaluation of the breating quality during speech in each condition by the patient with a horizontal visual analogical scale ranked from 0 to 10 (0= very uncomfortable and 10= very comfortable). The scale is 10 cm long ; the patient indicate his perceived sensation and the according measure (between 0 and 10) is recorded
Reading duration1 hourMeasurement of the duration for the reading of a predetermined text

Countries

France

Contacts

Primary ContactHélène Prigent, MD PhD
helene.prigent@aphp.fr0033147107911

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026